Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region

Aim. To assess dynamics of glycated hemoglobin levels and insulin doses per kg bw in children and adolescents with poorly controlled type 1 diabetes mellitus using insulin pumps. Materials and methods. Retrospective analysis of HbA1c levels and insulin doses per kg bw in children aged 2-17 years w...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Elena Efimovna Petryaykina, Olga Viktorovna Dukhareva, Irina Georgievna Rybkina, Ekaterina Alexandrovna Pronina, Tatiana Dmitrievna Mikhaylova, Irina Viktorovna Garyaeva, Eleonora Tavanovna Mandzhieva, Igor Eduardovich Volkov, Natalya Mikhailovna Grenkova
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2009
Materias:	type 1 diabetes mellitus children and adolescents insulin pump therapy glycated hemoglobin insulin requirement efficiency of therapy Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/74cebe09b5b9493a9ff7a5c25c49416b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:74cebe09b5b9493a9ff7a5c25c49416b
record_format	dspace
spelling	oai:doaj.org-article:74cebe09b5b9493a9ff7a5c25c49416b2021-11-14T09:00:13ZInsulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region2072-03512072-037810.14341/2072-0351-5455https://doaj.org/article/74cebe09b5b9493a9ff7a5c25c49416b2009-09-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/5455https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Aim. To assess dynamics of glycated hemoglobin levels and insulin doses per kg bw in children and adolescents with poorly controlled type 1 diabetes mellitus using insulin pumps. Materials and methods. Retrospective analysis of HbA1c levels and insulin doses per kg bw in children aged 2-17 years with DM1 (mean duration 5.3?3.1) before and 18 months after onset of insulin pump therapy (Medtronic Minimed 712 and 722) with a short-acting insulin analog Novopramid (Novo Nordisk) or Humalog (Ely Lilly) given to 55 (52,4%) and 50 (47,6%) of the patients respectively. НbА1с level and mean daily insulin dose per kg bw were determined when a patient visited the doctors office every 3 months. Results. Insulin pump therapy in patients with initially poorly controlled DM1 resulted in a decrease of HbA1c from 9.8?0.8 to 7,8?0,5% within 18 months after its beginning (pElena Efimovna PetryaykinaOlga Viktorovna DukharevaIrina Georgievna RybkinaEkaterina Alexandrovna ProninaTatiana Dmitrievna MikhaylovaIrina Viktorovna GaryaevaEleonora Tavanovna MandzhievaIgor Eduardovich VolkovNatalya Mikhailovna GrenkovaEndocrinology Research Centrearticletype 1 diabetes mellituschildren and adolescentsinsulin pump therapyglycated hemoglobininsulin requirementefficiency of therapyNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 12, Iss 3, Pp 60-63 (2009)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	type 1 diabetes mellitus children and adolescents insulin pump therapy glycated hemoglobin insulin requirement efficiency of therapy Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	type 1 diabetes mellitus children and adolescents insulin pump therapy glycated hemoglobin insulin requirement efficiency of therapy Nutritional diseases. Deficiency diseases RC620-627 Elena Efimovna Petryaykina Olga Viktorovna Dukhareva Irina Georgievna Rybkina Ekaterina Alexandrovna Pronina Tatiana Dmitrievna Mikhaylova Irina Viktorovna Garyaeva Eleonora Tavanovna Mandzhieva Igor Eduardovich Volkov Natalya Mikhailovna Grenkova Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region
description	Aim. To assess dynamics of glycated hemoglobin levels and insulin doses per kg bw in children and adolescents with poorly controlled type 1 diabetes mellitus using insulin pumps. Materials and methods. Retrospective analysis of HbA1c levels and insulin doses per kg bw in children aged 2-17 years with DM1 (mean duration 5.3?3.1) before and 18 months after onset of insulin pump therapy (Medtronic Minimed 712 and 722) with a short-acting insulin analog Novopramid (Novo Nordisk) or Humalog (Ely Lilly) given to 55 (52,4%) and 50 (47,6%) of the patients respectively. НbА1с level and mean daily insulin dose per kg bw were determined when a patient visited the doctors office every 3 months. Results. Insulin pump therapy in patients with initially poorly controlled DM1 resulted in a decrease of HbA1c from 9.8?0.8 to 7,8?0,5% within 18 months after its beginning (p
format	article
author	Elena Efimovna Petryaykina Olga Viktorovna Dukhareva Irina Georgievna Rybkina Ekaterina Alexandrovna Pronina Tatiana Dmitrievna Mikhaylova Irina Viktorovna Garyaeva Eleonora Tavanovna Mandzhieva Igor Eduardovich Volkov Natalya Mikhailovna Grenkova
author_facet	Elena Efimovna Petryaykina Olga Viktorovna Dukhareva Irina Georgievna Rybkina Ekaterina Alexandrovna Pronina Tatiana Dmitrievna Mikhaylova Irina Viktorovna Garyaeva Eleonora Tavanovna Mandzhieva Igor Eduardovich Volkov Natalya Mikhailovna Grenkova
author_sort	Elena Efimovna Petryaykina
title	Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region
title_short	Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region
title_full	Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region
title_fullStr	Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region
title_full_unstemmed	Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region
title_sort	insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the moscow region
publisher	Endocrinology Research Centre
publishDate	2009
url	https://doaj.org/article/74cebe09b5b9493a9ff7a5c25c49416b
work_keys_str_mv	AT elenaefimovnapetryaykina insulinpumptherapyoftype1diabetesmellitusinchildrenandadolescentsinthemoscowregion AT olgaviktorovnadukhareva insulinpumptherapyoftype1diabetesmellitusinchildrenandadolescentsinthemoscowregion AT irinageorgievnarybkina insulinpumptherapyoftype1diabetesmellitusinchildrenandadolescentsinthemoscowregion AT ekaterinaalexandrovnapronina insulinpumptherapyoftype1diabetesmellitusinchildrenandadolescentsinthemoscowregion AT tatianadmitrievnamikhaylova insulinpumptherapyoftype1diabetesmellitusinchildrenandadolescentsinthemoscowregion AT irinaviktorovnagaryaeva insulinpumptherapyoftype1diabetesmellitusinchildrenandadolescentsinthemoscowregion AT eleonoratavanovnamandzhieva insulinpumptherapyoftype1diabetesmellitusinchildrenandadolescentsinthemoscowregion AT igoreduardovichvolkov insulinpumptherapyoftype1diabetesmellitusinchildrenandadolescentsinthemoscowregion AT natalyamikhailovnagrenkova insulinpumptherapyoftype1diabetesmellitusinchildrenandadolescentsinthemoscowregion
_version_	1718429661017407488

Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region

Ejemplares similares